DuPont Pioneer, Bunge to contract high oleic beans

0
157
soybean field

DES MOINES, Iowa, — DuPont Pioneer announced that processor-paid premiums will be offered for Pioneer brand Plenish high oleic soybeans contracted for the 2018 growing season in northeast Indiana and northwest Ohio.

Soybeans contracted under this program will be processed by Bunge in Delphos and Bellevue, Ohio, and their network of locations, providing growers with access to this value-added market opportunity.

“Plenish high oleic soybean oil provides companies and foodservice operators a sustainable, U.S.-grown, soy-based trans-fat alternative with 0 grams trans-fat per serving and 20 percent less saturated fat than commodity soybean oil,” said Mike Lund, vice president, product management for Bunge.

Incentive

Farmers who contract to grow Plenish high oleic soybeans in the 2018 growing season will receive a 40 cent per bushel incentive for producing the soybeans for buyers call.

There are a limited number of acres in the 2018 program.

The development and commercialization of Plenish high oleic soybeans illustrates how biotechnology can provide direct benefits to the food industry, consumers and growers.

Improved profile

The improved fatty acid profile provides the highest oxidative stability level of any commercially produced soybean oil.

Additionally, this enhanced stability means longer fry life in restaurant applications and less polymerized oil buildup on equipment, which reduces cleaning costs.

The oil’s stability extends the shelf life for packaged food products without sacrificing flavor and eliminates the need for artificial preservatives, creating the opportunity for a cleaner ingredient label.

These high oleic soybeans are now approved for export to a number of U.S. soybean export markets. They most recently received import approval in Europe.

For more information on Plenish high oleic soybeans, visit www.plenish.com.

Get our Top Stories in Your Inbox

Next step: Check your inbox to confirm your subscription.

NO COMMENTS

LEAVE A REPLY

We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.

Receive emails as this discussion progresses.